17 results
8-K
EX-1.1
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
other person by virtue of this Agreement or the retention of the Placement Agents hereunder, all of which are hereby expressly waived.
SECTION 9
424B4
CNSP
Cns Pharmaceuticals Inc
31 Jan 24
Prospectus supplement with pricing info
4:27pm
embolism
Convulsion
Urinary tract infection
Peripheral motor neuropathy
Peripheral sensory neuropathy
Urinary retention
Nausea
Vomiting
Constipation
8-K
EX-1.1
sa1dg7n
12 Feb 21
Entry into a Material Definitive Agreement
5:13pm
10-K
kvs58w4xukmt1ji ei1
12 Mar 20
Annual report
4:06pm
424B4
y6nr146tq d25
8 Nov 19
Prospectus supplement with pricing info
4:25pm
S-1
rcvj6cv976
28 Jun 19
IPO registration
5:04pm
DRS
n6tv91aj15oer334aq
28 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next